Andrew Lingard completed his Bachelor’s of Science and Master’s of Experimental Medicine at McGill University, where he was also a member of the McGill-CIHR Drug Development Training Program. He received his Medical Doctorate with Distinction from Saba University in the Dutch Caribbean. He is interested in the intersection of pathology with drug development, with a particular interest in neurological disease, immune/inflammatory conditions, and board games.